6505--770-25-1-801-0073 - National CMOP D0286 DORZOLAMIDE -(VA-25-00021409) (VA-25-00021409)
ID: 36C77025Q0125Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/bb99f08a0ef84f0090bd10084a3c28bb/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting proposals for the procurement of dorzolamide hydrochloride ophthalmic solution under the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The primary objective is to acquire this pharmaceutical product in various quantities, ensuring compliance with specific contract terms, delivery standards, and regulatory requirements, including adherence to the Drug Supply Chain Security Act (DSCSA). This procurement is crucial for maintaining the quality and availability of essential medications for veterans' healthcare needs. Interested vendors must submit their quotes by January 30, 2025, at 3:00 PM Central Time, and can contact Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov for further information.

    Point(s) of Contact
    Kelley CunninghamContract Specialist
    kelley.cunningham@va.gov
    Files
    Title
    Posted
    36C77025Q0125_1.docx
    The document outlines a solicitation from the Department of Veterans Affairs (VA) for pharmaceutical supplies under the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The primary objective is to acquire dorzolamide hydrochloride ophthalmic solution in various quantities, adhering to specific contract terms and conditions for delivery and compliance standards. The solicitation emphasizes the need for shippable products via the United States Postal Service (USPS) and mandates detailed documentation for invoicing, including the National Drug Code (NDC) for each product. Proposals must include additional certifications and licenses, ensuring vendor compliance with the Drug Supply Chain Security Act (DSCSA). Key highlights include guidelines for delivery coordination, pharmaceutical labeling, and requirements for electronic submission of invoices. The procurement process encourages participation from small businesses and outlines clear criteria for accepted products, reiterating the importance of maintaining standards for quality, packaging, and labeling. The document is structured to guide contractors through compliance obligations while aligning with federal acquisition regulations. Overall, this solicitation reflects the VA's commitment to providing essential pharmaceutical products efficiently and securely to support veterans' healthcare needs.
    36C77025Q0125.docx
    The Department of Veterans Affairs (VA), through Network Contracting Office 15, is preparing to issue a solicitation for the procurement of Dorzolamide Hydrochloride Ophthalmic Solution for delivery to various VA Consolidated Mail Outpatient Pharmacies (CMOP). This presolicitation notice outlines the requirement for a total of 12,000 bottles across multiple locations, including Leavenworth, Chelmsford, Tucson, Lancaster, Murfreesboro, Hines, and Ladson, each requiring specific quantities. The solicitation, numbered 36C77025Q0125, is set aside for small businesses under Product Service Code 6505 and NAICS Code 325412. The anticipated timeline includes an estimated issue date of January 27, 2025, with responses due by January 30, 2025, and a delivery timeframe of 10 days after receipt of the order. Interested vendors must submit various documents, including a quote, state wholesale distributor license, and Buy American Act certificate via email. The notice emphasizes compliance with the Drug Supply Chain Security Act and requires documentation for over-the-counter products. This procurement aims to address the pharmaceutical needs of veterans effectively.
    S02_Pricing Schedule_Q0125.xlsx
    The document outlines a Request for Quotes (RFQ) from the federal government for the procurement of pharmaceuticals, specifically DORZOLAMIDE HCL 2% OPH SOLN 10ML, under RFQ number 36C77025Q0125. It specifies a delivery timeline of 10 days post-receipt of order and mandates that vendors complete a solicitation cover page (SF1449), a quote spreadsheet, and provide documentation such as a State Wholesale Distributor License and OEM authorization. The submission deadline for quotes is set for January 30, 2025, at 3:00 PM Central Time. Vendors are restricted to one quote submission and must note expiration dates for products, ensuring they exceed one year from the delivery date. The document lists multiple quantities and associated pricing for the medical supply item across several VA Consolidated Mail Outpatient Pharmacy (CMOP) facilities. This RFQ emphasizes compliance with the Buy American Act for any non-domestic product proposals and provides contact information for communication. The overall aim is to facilitate the procurement process efficiently while adhering to regulatory requirements for medical supplies in the Veterans Affairs system.
    Similar Opportunities
    6505--Domestic Pharmaceuticals/Med/Surge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting a Sources Sought notice to identify qualified domestic pharmaceutical manufacturers capable of supplying a range of medications for the Consolidated Mail Outpatient Pharmacy (CMOP). The procurement aims to ensure a reliable supply of domestically manufactured pharmaceuticals, including glucose test strips, hypertension treatments, and various other essential medications. This initiative is crucial for maintaining the health and well-being of veterans, as it supports ongoing healthcare needs. Interested manufacturers must submit their capability statements by February 5, 2025, to Josie Linaweaver at josie.linaweaver@va.gov, and are reminded to register in the System for Award Management (SAM) prior to contract award.
    National CMOP CHLORHEXIDINE GLUCONATE
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting quotes for the procurement of Chlorhexidine Gluconate 4% Top Liquid (120ML) through RFQ 36C77025Q0104, aimed at supplying various VA Consolidated Mail Outpatient Pharmacy (CMOP) facilities. Vendors are required to submit their quotes by January 31, 2025, at 4:00 PM CST, along with necessary documentation including a signed solicitation cover page, an Excel pricing schedule, and proof of a valid State Wholesale Distributor License. This procurement is critical for ensuring the availability of pharmaceuticals that meet the healthcare needs of veterans, with strict compliance to federal regulations and quality standards mandated throughout the process. Interested vendors can reach out to Sarah Fry at sarah.fry2@va.gov or call 913-758-9935 for further inquiries.
    6505--Tamsulosin Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Tamsulosin Hydrochloride capsules as part of its Pharmaceutical Prime Vendor (PPV) Programs. Offerors are required to submit pricing for a base year and four option years, ensuring compliance with FDA standards and providing a unique 11-digit National Drug Code (NDC) for each product. This procurement is vital for maintaining a consistent supply of necessary pharmaceuticals to federal healthcare facilities, adhering to regulatory standards while ensuring availability and pricing stability. Interested parties must submit their offers by February 24, 2025, at 2:30 PM CST, and can contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further information.
    6505--Bevacizumab Injection
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to procure Bevacizumab Injections through a Request for Proposal (RFP) designated as 36E79725R0019. This procurement aims to secure an uninterrupted supply of Bevacizumab, a critical pharmaceutical product used in the treatment of various medical conditions, for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will span one year with four additional one-year option periods, and the estimated annual requirements include various package sizes of Bevacizumab, with a total estimated usage of over 100,000 vials. Interested offerors must submit their proposals by March 4, 2025, at 2:30 PM Central Time, and can direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.
    6505--Carbidopa/Levodopa SA Tablet
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking pharmaceutical suppliers to establish a national contract for the provision of Carbidopa/Levodopa SA tablets through its Pharmaceutical Prime Vendor program. The Request for Proposal (RFP) outlines specific requirements for potential contractors, including pricing structures for the base year and four option years, compliance with the Drug Supply Chain Security Act, and the necessity for Good Manufacturing Practices (cGMP) status. This procurement is crucial for ensuring a reliable supply of essential medications for veteran and military healthcare systems across the nation. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details regarding the proposal submission process and deadlines.
    6515--Pharmacy Management System ScriptPro Brand name or Equal
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of a ScriptPro Pharmacy Management System or an equivalent solution, as outlined in the combined synopsis/solicitation RFQ 36C26225Q0148. This procurement aims to enhance pharmacy management capabilities across various Veterans Integrated Service Network (VISN) 22 medical facilities and clinics, ensuring high-quality healthcare service delivery through reliable technological advancements. Interested vendors are encouraged to participate, particularly small businesses, including those owned by veterans and women, with bids due by February 4, 2025, at 7:00 AM PST. For inquiries, potential bidders should contact Contracting Officer Anthony Dela Cruz at anthony.delacruz@va.gov or by phone at 562-766-2284.
    6505--Baclofen Tablets (VA-25-00026620)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Baclofen Tablets under the solicitation titled "6505--Baclofen Tablets (VA-25-00026620)." The primary objective of this procurement is to establish a reliable source for various strengths of Baclofen tablets, ensuring consistent availability and quality at pre-negotiated prices, while complying with the Drug Supply Chain Security Act and Good Manufacturing Practices. This contract is crucial for maintaining the pharmaceutical needs of VA facilities, addressing issues such as compliance, backorders, and recalls. Interested offerors must submit their proposals by February 5, 2025, at 2:30 PM CST, and can direct inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--Fluticasone Propionate 50 MCG/Spray Soln, Nasal, 16GM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Fluticasone Propionate 50 MCG/Spray solution, nasal, 16GM, intended for use by various federal agencies including the Department of Defense, Bureau of Prisons, and Indian Health Service. The objective of this procurement is to secure a reliable and uninterrupted supply of this medication for a contract period of one year, with the possibility of four additional one-year extensions. This medication is crucial for treating nasal conditions, and the estimated annual requirement is approximately 5,784,828 bottles. The solicitation will be available electronically on or around February 11, 2025, with a closing date set for February 25, 2025. Interested vendors should direct inquiries to Michael Olszewski at michael.olszewski@va.gov or call 708-786-4966.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Rituximab and Biosimilars
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) designated as 36E79725R0021 for the procurement of Rituximab and its biosimilars, aimed at ensuring a reliable supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will span one year with four additional one-year options, emphasizing the necessity of maintaining an uninterrupted supply chain for these critical medications. Offerors must provide the exact product names along with unique National Drug Codes (NDC), with estimated annual requirements of 17,858 vials of Rituximab 10mg/ml and 25,111 vials of the 50mg/ml variant. The solicitation is expected to be published around February 17, 2025, with a closing date around March 4, 2025; interested parties should direct inquiries to Deb Fassl at Deborah.Fassl@va.gov.